Anixa Cash And Short Term Investments vs Non Current Liabilities Total Analysis

ANIX Stock  USD 3.14  0.16  4.85%   
Anixa Biosciences financial indicator trend analysis is way more than just evaluating Anixa Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anixa Biosciences is a good investment. Please check the relationship between Anixa Biosciences Cash And Short Term Investments and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Cash And Short Term Investments vs Non Current Liabilities Total

Cash And Short Term Investments vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anixa Biosciences Cash And Short Term Investments account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Anixa Biosciences' Cash And Short Term Investments and Non Current Liabilities Total is -0.6. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Anixa Biosciences, assuming nothing else is changed. The correlation between historical values of Anixa Biosciences' Cash And Short Term Investments and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Anixa Biosciences are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Cash And Short Term Investments i.e., Anixa Biosciences' Cash And Short Term Investments and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.6
Relationship DirectionNegative 
Relationship StrengthWeak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Anixa Biosciences balance sheet. This account contains Anixa Biosciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Anixa Biosciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Non Current Liabilities Total

Most indicators from Anixa Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to rise to about 134.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024.

Anixa Biosciences fundamental ratios Correlations

0.810.390.980.43-0.55-0.670.53-0.540.990.880.20.30.82-0.290.430.99-0.2-0.34-0.61-0.52-0.320.81-0.32-0.230.64
0.810.630.80.21-0.13-0.670.07-0.530.80.890.020.50.84-0.230.210.81-0.17-0.32-0.38-0.53-0.120.91-0.12-0.260.5
0.390.630.28-0.290.21-0.45-0.150.170.320.470.080.270.520.47-0.290.34-0.18-0.470.030.140.470.540.47-0.44-0.05
0.980.80.280.51-0.59-0.650.54-0.671.00.90.130.360.81-0.460.511.0-0.19-0.27-0.63-0.67-0.440.8-0.44-0.150.7
0.430.21-0.290.51-0.460.050.44-0.710.490.30.00.380.08-0.611.00.48-0.130.4-0.53-0.61-0.510.26-0.510.560.92
-0.55-0.130.21-0.59-0.460.29-0.980.4-0.59-0.320.050.0-0.250.41-0.46-0.560.120.190.370.410.270.010.270.03-0.34
-0.67-0.67-0.45-0.650.050.29-0.280.36-0.66-0.820.21-0.46-0.920.120.05-0.670.050.850.020.320.34-0.590.340.78-0.15
0.530.07-0.150.540.44-0.98-0.28-0.320.560.27-0.02-0.050.23-0.290.440.53-0.03-0.22-0.32-0.3-0.22-0.05-0.22-0.060.31
-0.54-0.530.17-0.67-0.710.40.36-0.32-0.62-0.660.33-0.54-0.470.88-0.71-0.62-0.02-0.090.460.940.74-0.50.74-0.23-0.77
0.990.80.321.00.49-0.59-0.660.56-0.620.890.140.340.81-0.380.491.0-0.18-0.31-0.62-0.6-0.390.8-0.39-0.190.68
0.880.890.470.90.3-0.32-0.820.27-0.660.89-0.120.570.95-0.380.30.9-0.22-0.49-0.44-0.63-0.440.87-0.44-0.370.58
0.20.020.080.130.00.050.21-0.020.330.14-0.12-0.48-0.090.280.00.150.110.3-0.120.250.220.20.220.110.05
0.30.50.270.360.380.0-0.46-0.05-0.540.340.57-0.480.51-0.350.380.35-0.2-0.270.03-0.47-0.370.44-0.37-0.160.52
0.820.840.520.810.08-0.25-0.920.23-0.470.810.95-0.090.51-0.20.080.82-0.11-0.68-0.25-0.44-0.380.81-0.38-0.620.38
-0.29-0.230.47-0.46-0.610.410.12-0.290.88-0.38-0.380.28-0.35-0.2-0.61-0.380.02-0.250.350.930.76-0.220.76-0.35-0.59
0.430.21-0.290.511.0-0.460.050.44-0.710.490.30.00.380.08-0.610.48-0.130.4-0.53-0.61-0.510.26-0.510.560.92
0.990.810.341.00.48-0.56-0.670.53-0.621.00.90.150.350.82-0.380.48-0.18-0.3-0.62-0.6-0.390.82-0.39-0.190.68
-0.2-0.17-0.18-0.19-0.130.120.05-0.03-0.02-0.18-0.220.11-0.2-0.110.02-0.13-0.180.080.450.1-0.11-0.18-0.11-0.06-0.18
-0.34-0.32-0.47-0.270.40.190.85-0.22-0.09-0.31-0.490.3-0.27-0.68-0.250.4-0.30.08-0.28-0.120.04-0.20.040.950.26
-0.61-0.380.03-0.63-0.530.370.02-0.320.46-0.62-0.44-0.120.03-0.250.35-0.53-0.620.45-0.280.450.26-0.520.26-0.42-0.63
-0.52-0.530.14-0.67-0.610.410.32-0.30.94-0.6-0.630.25-0.47-0.440.93-0.61-0.60.1-0.120.450.66-0.490.66-0.25-0.68
-0.32-0.120.47-0.44-0.510.270.34-0.220.74-0.39-0.440.22-0.37-0.380.76-0.51-0.39-0.110.040.260.66-0.291.0-0.03-0.55
0.810.910.540.80.260.01-0.59-0.05-0.50.80.870.20.440.81-0.220.260.82-0.18-0.2-0.52-0.49-0.29-0.29-0.170.59
-0.32-0.120.47-0.44-0.510.270.34-0.220.74-0.39-0.440.22-0.37-0.380.76-0.51-0.39-0.110.040.260.661.0-0.29-0.03-0.55
-0.23-0.26-0.44-0.150.560.030.78-0.06-0.23-0.19-0.370.11-0.16-0.62-0.350.56-0.19-0.060.95-0.42-0.25-0.03-0.17-0.030.4
0.640.5-0.050.70.92-0.34-0.150.31-0.770.680.580.050.520.38-0.590.920.68-0.180.26-0.63-0.68-0.550.59-0.550.4
Click cells to compare fundamentals

Anixa Biosciences Account Relationship Matchups

Anixa Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.5M36.3M30.4M25.5M29.4M30.8M
Other Current Liab845.8K1.1M1.7M1.8M2.0M2.1M
Total Current Liabilities1.2M1.3M2.0M2.0M2.3M2.4M
Total Stockholder Equity8.8M35.4M29.0M24.3M28.0M29.4M
Property Plant And Equipment Net54.3K254.0K212K166K149.4K132.1K
Net Debt(6.4M)(28.9M)(12.1M)(740K)(666K)(699.3K)
Retained Earnings(191.8M)(204.8M)(218.4M)(228.2M)(205.4M)(195.1M)
Cash6.4M29.1M12.4M915K1.1M999.6K
Non Current Assets Total84.3K254.0K212K166K190.9K181.4K
Cash And Short Term Investments9.1M35.7M29.7M23.8M27.4M28.8M
Common Stock Shares Outstanding22.2M28.6M30.4M31.0M35.6M37.4M
Liabilities And Stockholders Equity9.5M36.3M30.4M25.5M29.4M30.8M
Inventory1.0(2.4M)(2.6M)(46K)(41.4K)(39.3K)
Other Current Assets311.6K551.6K513K1.2M1.1M1.2M
Other Stockholder Equity200.4M239.9M247.1M252.2M290.1M304.6M
Total Liab1.2M1.5M2.2M2.2M2.5M2.2M
Property Plant And Equipment Gross54.3K254.0K212K166K149.4K132.1K
Total Current Assets9.4M36.0M30.2M25.4M29.2M30.6M
Non Currrent Assets Other910.2K(200.6K)30K(212K)(243.8K)(231.6K)
Net Receivables66.5K2.2K46K270K243K231.6K
Accounts Payable232.4K136K265K206K185.4K176.1K
Non Current Liabilities Total287.6K220.1K175K123K141.5K134.4K
Common Stock Total Equity189.1K203.3K242.5K309K278.1K264.2K
Short Term Investments2.6M6.6M17.3M22.9M26.4M27.7M
Common Stock242.5K300.5K309K311K279.9K265.9K
Property Plant Equipment200.6K54.3K254.0K212K243.8K256.0K
Net Tangible Assets5.2M8.8M35.4M29.0M33.4M35.1M
Noncontrolling Interest In Consolidated Entity(251.4K)(423.0K)(497.0K)(847K)(762.3K)(724.2K)
Retained Earnings Total Equity(170.2M)(181.8M)(191.8M)(218.4M)(196.5M)(206.4M)
Capital Surpluse175.4M186.8M200.4M247.1M284.2M181.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.